Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT Conclusion - On a good track...

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Apr 05, 2022 10:27am

204 Views

Post# 34576459

RE:RE:RE:RE:RE:TLT Conclusion - On a good track...

Sounds good, so we have a ways to go before full data is actually analysed and we can get concrete CR rates. Was hoping that we have good enough results now to get BTD, which IMO we do compared to other treatments available at this time. We may get that news shortly because they didnt want to post they already applied for BTD before they actually receive it. IMO

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth